Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugate
- 1 January 1993
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8) , 1177-1183
- https://doi.org/10.1016/s0959-8049(05)80311-9
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2Journal of Immunological Methods, 1993
- A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancerBioorganic & Medicinal Chemistry Letters, 1991
- Influence of recombinant tumour necrosis factor a on blood flow and antibody localisation in human tumour xenografts in nude miceZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugateBiochemical Pharmacology, 1991
- In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphateBioconjugate Chemistry, 1991
- Construction and chemotherapeutic potential of carboxypeptidase-A/monoclonal antibody conjugateAdvances in Enzyme Regulation, 1991
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990
- The diffusion of a tumour-specific monoclonal antibody in lymphoma infiltrated spleenBritish Journal of Cancer, 1987
- Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity methodEuropean Journal of Biochemistry, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976